Expanding horizons in overcoming therapeutic resistance in castration-resistant prostate cancer: targeting the androgen receptor-regulated tumor immune microenvironment

被引：9
作者：
Cheng, Bisheng [1 ]
Huang, Hai [1 ]
机构：
[1] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Urol, Guangzhou 510120, Peoples R China
来源：
CANCER BIOLOGY & MEDICINE | 2023年 / 20卷 / 08期
基金：
中国国家自然科学基金;
关键词：
D O I：
10.20892/j.issn.2095-3941.2023.0256
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：568 / 574
页数：7
相关论文
共 19 条
  • [1] Clinical activity of pembrolizumab in metastatic prostate cancer with microsatellite instability high (MSI-H) detected by circulating tumor DNA
    Barata, Pedro
    Agarwal, Neeraj
    Nussenzveig, Roberto
    Gerendash, Benjamin
    Jaeger, Ellen
    Hatton, Whitley
    Ledet, Elisa
    Lewis, Brian
    Layton, Jodi
    Babiker, Hani
    Bryce, Alan
    Garje, Rohan
    Stein, Cy
    Kiedrowski, Lesli
    Saylor, Philip
    Sartor, Oliver
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [2] Cuproptosis illustrates tumor micro-environment features and predicts prostate cancer therapeutic sensitivity and prognosis
    Cheng, Bisheng
    Tang, Chen
    Xie, Junjia
    Zhou, Qianghua
    Luo, Tianlong
    Wang, Qiong
    Huang, Hai
    [J]. LIFE SCIENCES, 2023, 325
  • [3] The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients
    Del Re, Marzia
    Biasco, Elisa
    Crucitta, Stefania
    Derosa, Lisa
    Rofi, Eleonora
    Orlandini, Cinzia
    Miccoli, Mario
    Galli, Luca
    Falcone, Alfredo
    Jenster, Guido W.
    van Schaik, Ron H.
    Danesi, Romano
    [J]. EUROPEAN UROLOGY, 2017, 71 (04) : 680 - 687
  • [4] Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022
    Gillessen, Silke
    Bossi, Alberto
    Davis, Ian D.
    de Bono, Johann
    Fizazi, Karim
    James, Nicholas D.
    Mottet, Nicolas
    Shore, Neal
    Small, Eric
    Smith, Mathew
    Sweeney, Christopher
    Tombal, Bertrand
    Antonarakis, Emmanuel S.
    Aparicio, Ana M.
    Armstrong, Andrew J.
    Attard, Gerhardt
    Beer, Tomasz M.
    Beltran, Himisha
    Bjartell, Anders
    Blanchard, Pierre
    Briganti, Alberto
    Bristow, Rob G.
    Bulbul, Muhammad
    Caffo, Orazio
    Castellano, Daniel
    Castro, Elena
    Cheng, Heather H.
    Chi, Kim N.
    Chowdhury, Simon
    Clarke, Caroline S.
    Clarke, Noel
    Daugaard, Gedske
    De, Maria
    Duran, Ignacio
    Eeles, Ros
    Efstathiou, Eleni
    Efstathiou, Jason
    Ekeke, Onyeanunam Ngozi
    Evans, Christopher P.
    Fanti, Stefano
    Feng, Felix Y.
    Fonteyne, Valerie
    Fossati, Nicola
    Frydenberg, Mark
    Daniel, Vvww
    Gleave, Martin
    Gravis, Gwenaelle
    Halabi, Susan
    Heinrich, Daniel
    Herrmann, Ken
    [J]. EUROPEAN UROLOGY, 2023, 83 (03) : 267 - 293
  • [5] Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial transcriptomic analyses
    Hirz, Taghreed
    Mei, Shenglin
    Sarkar, Hirak
    Kfoury, Youmna
    Wu, Shulin
    Verhoeven, Bronte M.
    Subtelny, Alexander O.
    Zlatev, Dimitar V.
    Wszolek, Matthew W.
    Salari, Keyan
    Murray, Evan
    Chen, Fei
    Macosko, Evan Z.
    Wu, Chin-Lee
    Scadden, David T.
    Dahl, Douglas M.
    Baryawno, Ninib
    Saylor, Philip J.
    Kharchenko, Peter V.
    Sykes, David B.
    [J]. NATURE COMMUNICATIONS, 2023, 14 (01)
  • [6] CXCL12γ Promotes Metastatic Castration-Resistant Prostate Cancer by Inducing Cancer Stem Cell and Neuroendocrine Phenotypes
    Jung, Younghun
    Cackowski, Frank C.
    Yumoto, Kenji
    Decker, Ann M.
    Wang, Jingcheng
    Kim, Jin Koo
    Lee, Eunsohl
    Wang, Yugang
    Chung, Jae-Seung
    Gursky, Amy M.
    Krebsbach, Paul H.
    Pienta, Kenneth J.
    Morgan, Todd M.
    Taichman, Russell S.
    [J]. CANCER RESEARCH, 2018, 78 (08) : 2026 - 2039
  • [7] WNT5A induces castration-resistant prostate cancer via CCL2 and tumour-infiltrating macrophages
    Lee, Geun Taek
    Kwon, Seok Joo
    Kim, Jongmyung
    Kwon, Young Suk
    Lee, Nara
    Hong, Jeong Hee
    Jamieson, Christina
    Kim, Wun-Jae
    Kim, Isaac Yi
    [J]. BRITISH JOURNAL OF CANCER, 2018, 118 (05) : 670 - 678
  • [8] ARID1A loss induces polymorphonuclear myeloid-derived suppressor cell chemotaxis and promotes prostate cancer progression
    Li, Ni
    Liu, Qiuli
    Han, Ying
    Pei, Siyu
    Cheng, Bisheng
    Xu, Junyu
    Miao, Xiang
    Pan, Qiang
    Wang, Hanling
    Guo, Jiacheng
    Wang, Xuege
    Zhang, Guoying
    Lian, Yannan
    Zhang, Wei
    Zang, Yi
    Tan, Minjia
    Li, Qintong
    Wang, Xiaoming
    Xiao, Yichuan
    Hu, Guohong
    Jiang, Jun
    Huang, Hai
    Qin, Jun
    [J]. NATURE COMMUNICATIONS, 2022, 13 (01)
  • [9] Liu YZ, 2019, SCI TRANSL MED, V11, DOI [10.1126/scitranslmed.aax9364, 10.1126/scitranslmed.aaw4993]
  • [10] Sprouty2 loss-induced IL6 drives castration-resistant prostate cancer through scavenger receptor B1
    Patel, Rachana
    Fleming, Janis
    Mui, Ernest
    Loveridge, Carolyn
    Repiscak, Peter
    Blomme, Arnaud
    Harle, Victoria
    Salji, Mark
    Ahmad, Imran
    Teo, Katy
    Hamdy, Freddie C.
    Hedley, Ann
    van den Broek, Niels
    Mackay, Gillian
    Edwards, Joanne
    Sansom, Owen J.
    Leung, Hing Y.
    [J]. EMBO MOLECULAR MEDICINE, 2018, 10 (04)
12